Dual specific binding proteins directed against IL-1 and/or IL-17
US9062108B2 · kind B2 · utility
6Cited by
138References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Engineered multivalent and multispecific binding proteins that bind IL-1β and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.